Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-26-075286

Director acquired 3,135 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Grissinger Michael Director 2026-06-16 Grant or award +3,135 6,024 D
Derivatives
Grissinger Michael Director 2026-06-16 Grant or award · Stock Options (Right to Buy) +12,555 12,555 D
Loading xslF345X06/tm2618211-8_4seq1.xml…